Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Revue du rhumatisme
Volume 76, n° 7
pages 599-601 (juillet 2009)
Doi : 10.1016/j.rhum.2009.04.002
accepted : 2 April 2009
Controverse sur le dextropropoxyphène
Controversy about dextropropoxyphene
 

Bernard Bannwarth a, , b , Christophe Richez a
a Service de rhumatologie, groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France 
b Laboratoire de thérapeutique, université Victor-Segalen, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France 

Auteur correspondant.

Mots clés : Antalgiques, Dextropropoxyphène, Co-proxamol, Retrait du marché

Keywords : Analgesics, Dextropropoxyphene, Co-proxamol, Withdrawal from the market



 Ne pas utiliser, pour citation, la référence française de cet article, mais sa référence anglaise dans le même volume de Joint Bone Spine .



© 2009  Société Française de Rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline